Novaremed, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics, a China-based clinical stage neuroscience biotech company, jointly announced the signing of an exclusive collaboration and commercialization agreement for non-opioid investigational drug, NRD.E1. The Novaremed’s innovative non-opioid drug is being developed for the treatment of diabetes-related neuropathic pain and other neuropathic pain indications. Under the […]
Three of Switzerland’s leading and most experienced companies in the gemstone cutting and setting industry have merged by by way of absorption. This merger between SERCAB, Proserto and VAL’HEURE has created the new
H2 Energy Europe, a Swiss pioneer in the fields of renewable energies and hydrogen technology, and Phillips 66 have concluded an agreement to develop up to 250 retail hydrogen refuelling stations across Germany, Austria and Denmark by 2026
There is a merger in cruise brokerage. The two Swiss tourism companies e-hoi and Cruise Center also want to strengthen their bargaining power with the cruise lines. Business, down during the pandemic, is picking up
Vivalto Santé has acquired a majority stake in Groupe CIC Santé as well as a stake in RXPM, a company also entirely owned by Dr. Maire which operates in the field of radiology. Groupe CIC
BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access
Swiss software company Netcetera has acquired routeRANK, the Lausanne-based specialist for reliable and environmentally friendly door-to-door route planning. With this strategic transaction, the two companies will provide IT solutions for multimodal mobility worldwide. The newly
The branding agency Intr has recently merged with the agency Staaacks. The merger aims to broaden the profile of the creative and consulting agency. Intr is a Bern-based agency specialising in branding, branded content and
Solvias, an independent pharmaceutical testing and manufacturing company, has acquired Netherlands-based Cergentis to bolster its biologics and cell & gene therapy testing capabilities. Cergentis marks Solvias’ second acquisition since partnering with health care investors Water
Niederer Kraft Frey has advised as Swiss counsel Alpha VCX and AH & Capital Partners on their acquisition of a majority stake in Infoniqa SQL. Alpha VCX is backed by the two investors Oskar Alexander
